- INSIGHTS
The Risk Of Remaining Status Quo
Why “doing nothing” may be the most expensive decision you make in 2026.
Medical inflation is trending toward double digits. Million-dollar claims have doubled in four years. Specialty drugs and gene therapies are rewriting the ceiling on catastrophic exposure.
The environment has changed, but the structure often hasn’t — and that’s where risk quietly compounds.
The Illusion of Stability
On paper, staying put feels safe — same carrier, same vendor stack.
But in today’s stop-loss market, “stable” often means:
- Open-entry pools with inconsistent underwriting
- Carrier-aligned partners with misaligned incentives
- No high-claim intervention
- Reactive cost containment
- Renewal volatility driven by other employers’ claims
The risk isn’t obvious in year one, but it becomes impossible to ignore in year three, four, and five. If you don’t get out while you can, you’ll pay for it later.
The Compounding Effect No One Talks About
Here’s what long-term trend really looks like:
If a $500,000 stop-loss premium increases at 20%+ annually (common in volatile captives/consortiums), over five years that employer could pay $4.49M total premium.
Inside a well-managed captive/consortium program with required cost containment trending at 6-8%, that same employer could pay $3.77M total premium.
That’s a $718,395 difference in five years — and that’s just stop-loss premium — not total plan spend.
Now apply that to fully insured employers starting at $1M+ premiums. The five-year difference can exceed $2.1 million, and over 10 years, $10M+.
Status quo doesn’t stay flat and the cost of remaining stagnant is high.
Why the Risk Is Growing
Million-Dollar Claims Are Accelerating
High-cost claims have increased 100% over the past four years. Some are now exceeding $12M. Without active claimant management, employers absorb that volatility through double digit premium renewals .
Specialty Drugs & Gene Therapies
One injectable can cost more than an entire department’s annual payroll. Without carve-outs or J-code management, these claims hit the plan unchecked.
Public Pools Prioritize Growth
Open-entry pools often accept groups without defined cost-containment standards. When performance slips, everyone pays.
Inflation Is Structural
Provider consolidation, aging populations, obesity trends, and post-COVID utilization aren’t temporary blips. They’re systemic drivers.
Remaining static in a structurally shifting market increases exposure every year.
The Hidden Cost: Loss of Predictability
Most CFOs don’t fear paying claims; they fear not knowing what is coming. When renewal swings jump from 6% to 30% based on a bad claimant year, budgeting becomes guesswork, strategic planning stalls, and trust erodes.
Predictability is not about avoiding claims. It’s about managing them and without structure, volatility becomes the default.
The Strategic Question
The real question for 2026 isn’t, “Can we negotiate a better renewal?”. It’s, “Is our structure built to outperform the market — or mirror it?”.
Because if your model simply reflects broader market volatility, then you’re not managing risk. You’re sharing it.
The Bottom Line
Remaining status quo in this environment is not neutral. It’s a decision — one that compounds financially, strategically, and reputationally. The employers that will win the next five years won’t be the ones who negotiate hardest each renewal. They’ll be the ones who redesigned their structure before volatility forced them to.
Are you managing risk — or just absorbing it?
Want renewal conversations without guesswork?
Stop playing roulette with a system that punishes volatility and rewards timing. Come see the Virtue Health difference.
John W. Sbrocco
@johnwsbrocco
IF YOU’RE A BROKER READY TO…
Elevate your clients’ healthcare strategy with a long-term, stable solution, it’s time to consider self-funding.
